These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3689626)

  • 1. The effect of a new inotropic agent, DPI 201-106, on systolic time intervals and the electrocardiogram in healthy subjects.
    Rüegg PC; Nüesch E
    Br J Clin Pharmacol; 1987 Oct; 24(4):453-8. PubMed ID: 3689626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cardiac electrophysiologic evaluation of the positive inotropic agent, DPI 201-106.
    Butrous GS; Debbas NM; Erwin J; Davies DW; Keller HP; Lunnon MW; Nathan AW; Camm AJ
    Eur Heart J; 1988 May; 9(5):489-97. PubMed ID: 3402464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers.
    Boyce M; Dunn K; Warrington S
    J Cardiovasc Pharmacol; 2001 Mar; 37(3):280-9. PubMed ID: 11243418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPI 201-106 for severe congestive heart failure.
    Kostis JB; Lacy CR; Raia JJ; Dworkin JH; Warner RG; Casazza LA
    Am J Cardiol; 1987 Dec; 60(16):1334-9. PubMed ID: 3318371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and bepridil: pharmacokinetic and pharmacodynamic interactions.
    Belz GG; Wistuba S; Matthews JH
    Clin Pharmacol Ther; 1986 Jan; 39(1):65-71. PubMed ID: 3484691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.
    James MA; Papouchado M; Channer KS; Jones JV; Marlow HF; Bastain W; Barker NP; Harry JD; Wardleworth AG
    Br J Clin Pharmacol; 1990 Apr; 29(4):447-53. PubMed ID: 2139340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
    Pritchett EL; Schulte MC; Schnell D; Marcello SR; Wilkinson WE; Page RL; Connolly SJ;
    J Clin Pharmacol; 2002 Apr; 42(4):388-94. PubMed ID: 11936563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic and electrophysiological effects of BDF 9148, a congener of DPI 201-106, in guinea-pig atria and papillary muscles.
    Brasch H; Iven H
    Br J Pharmacol; 1991 Aug; 103(4):1939-45. PubMed ID: 1912981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B; Fossler M; Liu F; Caltabiano S
    Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the novel cardiotonic agent DPI 201-106 in the anaesthetized rat.
    Fraser M; Törnquist K; Sellin LC
    Pharmacol Toxicol; 1988 May; 62(5):334-6. PubMed ID: 3413037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiocirculatory effects of Ro 11-2465, a selective 5-HT (serotonin) uptake inhibitor, in healthy volunteers.
    Gasic S; Korn A; Omer LM
    Eur J Clin Pharmacol; 1982; 21(5):357-61. PubMed ID: 7075639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Mondal SA; Assaf M; Liu L; O'Mara E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers.
    Gemmill JD; Howie CA; Meredith PA; Kelman AW; Rasmussen HS; Hillis WS; Elliott HL
    Br J Clin Pharmacol; 1991 Oct; 32(4):429-32. PubMed ID: 1958435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects.
    Clifton GD; Harrison MR; Wermeling DP; Long RA; Fleck RJ; Rolleri RL; Weller S; Brown AR; Welch RM
    Clin Pharmacol Ther; 1994 Jan; 55(1):55-63. PubMed ID: 8299318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.
    Holford NH; Coates PE; Guentert TW; Riegelman S; Sheiner LB
    Br J Clin Pharmacol; 1981 Feb; 11(2):187-95. PubMed ID: 7213522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.